News
News from the BioCity Campus

Event: "Orphan Drugs - Medicines for the Treatment of Rare Diseases"

Together with vfa  and the VCI e. V. Northeast Regional Association loads biosaxony you at 28.02.2023 sincerely to 24. biosaxony on site on the subject "Orphan drugs - medicines for the treatment of rare diseases" to Leipzig.

Rare diseases – or orphan diseases as they are also known – exist in all medical fields. A disease is considered rare in the EU if it affects no more than five in 10.000 people. There are an estimated 8.000 different rare diseases; in Germany about 4 million people suffer from one of them.

Research-based pharmaceutical companies not only offer medicines for common diseases, but also for rare diseases. To date, 200 orphan drugs have been approved in the EU. The companies are thus responding to the demands of self-help groups, doctors, politicians and the EU Commission for increased commitment in this area.

Information about the program and online registration see here.

The key data at a glance

Date:
February 28, 2023 // Starts at 17:00 p.m. (from 16:30 p.m. participant registration)

Place:
Fraunhofer Institute for Cell Therapy and Immunology IZI
Perlickstr. 1 | 04103 Leipzig

Price:
The event is free of charge. Registration deadline is February 24.02.2023, XNUMX.

 


previous news

BioCityfit! – Bicycle check on 21.03.2023

On Monday, March 21, 2023, from 8:00 a.m. in the courtyard of BIO CITY/bicycle parking space, a free bike check will take place again as part of the BioCityfit!

NextNews

New call for funding from February 16: Saxony continues validation of promising research results

Saxon validation funding is aimed at improving technology transfer between research and industry. From February 16, 2023, universities and non-university research institutions based in Saxony can again apply for a grant of 90 percent of the costs for projects to validate research results. Funding is available for projects with a project period of up to 18 months and eligible expenses/costs of up to EUR 250.000. Application deadline is April 13, 2023.